Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
Gematol Transfuziol ; 35(4): 19-22, 1990 Apr.
Artigo em Russo | MEDLINE | ID: mdl-2373343

RESUMO

The authors have developed a panel of monoclonal antibodies (MCA) of IPO series (Institute of Problems of Oncology, Kiev). RPMI-1788 cell line, Daudi, as well as splenocytes of a patient with hairy-cell leukemia were used for immunization of mice. It has been shown that IPO-3, IPO-10 and IPO-24 MCA are directed against differentiation antigens of human B-lymphocytes. IPO-4 MCA reveal the antigen of activated T- and B-cells. IPO-5 and IPO-20 MCA recognize HLA-ABC, while IPO-37 a common leucocytic antigen. IPO-38 MCA are directed against the nuclear antigen. The possibilities of using IPO MCA in hematology have been discussed.


Assuntos
Anticorpos Monoclonais , Leucemia/diagnóstico , Linfoma/diagnóstico , Academias e Institutos , Animais , Anticorpos Monoclonais/biossíntese , Anticorpos Monoclonais/imunologia , Antígenos CD/imunologia , Diagnóstico Diferencial , Humanos , Leucemia/imunologia , Linfócitos/imunologia , Linfoma/imunologia , Oncologia , Camundongos , Ucrânia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...